Docencia

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

Dra. Ana González-Cordón.
Servicio de Enfermedades Infecciosas. Hospital Clínic de Barcelona

Sex Differences in People Aging with HIV

Dr. Vicente Boix.
Unidad de Enfermedades Infecciosas. Hospital General Universitario de Alicante

Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) maintains HIV-1 virologic suppression through 48 weeks: results of the DRIVE-SHIFT trial.

Dra. Hortensia Álvarez.
Unidad de Enfermedades Infecciosas, Servicio Medicina Interna. Complejo Hospitalario Universitario de Ferrol, A Coruña

Incidence and Risk Factors for Invasive Pneumococcal Disease and Communityacquired Pneumonia in Human Immunodeficiency Virus–Infected Individuals in a High-income SeBng

Dra. Inés Suárez García.
Hospital Infanta Sofía, Madrid.

On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.

Dr. Pablo Bachiller Luque.
Unidad de Enfermedades Infecciosas. S. Medicina Interna Complejo Asistencial de Segovia

Comorbidity and polypharmacy among women living with HIV in British Columbia

Dr. Vicente Boix.
Unidad de Enfermedades Infecciosas. Hospital General Universitario de Alicante

Prevalence and incidence of HPV infection in men having sex with men enrolled in a PrEP study: A sub-study of the ANRS IPERGAY trial.

Dra. Ana González-Cordón.
Servicio de Enfermedades Infecciosas. Hospital Clínic de Barcelona.

Efficacy and safety of dolutegravirrilpivirine for maintenance of virological suppression in adults with HIV-1: 100-week data from the randomised, openlabel, phase 3 SWORD-1 and WORD-2 studies.

Dra. Hortensia Álvarez.
Unidad de Enfermedades Infecciosas, Servicio Medicina Interna. Complejo Hospitalario Universitario de Ferrol, A Coruña

One month of Rifapentine Plus Isoniazid to prevent HIV-related Tuberculosis

Dra. Inés Suárez-García.
Universidad Europea de Madrid. Hospital Universitario Infanta Sofía, Madrid.

Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1 B, Double- Blind, Lacebocontrolled Trial

Dra. Isabel Viciana Ramos.
Servicio de Microbiología – UGC Infecciosos. Hospital Virgen de la Victoria, Málaga.

Impact of early antiretroviral treatment on sexual behaviour: a randomised comparison

Dr. Pablo Bachiller Luque.
Enfermedades Infecciosas – S. Medicina Interna. Complejo Asistencial de Segovia.

Frailty Is an Independent Risk Factor for Mortality, Cardiovascular Disease, Bone Desease, and Diabetes Among Aging Adults With Human Immunodeficiency Virus

Dr. Vicente Boix.
Unidad de Enfermedades Infecciosas. Hospital General Universitario de Alicante. ISABIAL

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

Dra. Ana González-Cordón. Servicio de Enfermedades Infecciosas. Hospital Clínic de Barcelona.

Clinical impact and cost-effectiveness of genotype testing at HIV diagnosis in the United States

Dra. Hortensia Álvarez. Unidad de Enfermedades Infecciosas, Servicio Medicina Interna. Complejo Hospitalario Universitario de Ferrol, A Coruña.

Effects of Pre-exposure Prophylaxis for the Prevention of Hiv Infection on Sexual Risk Behavior in Men Who Have Sex With Men: a Systematic Review and Meta-analysis

Dra. Inés Suárez-García. Hospital Infanta Sofía, Madrid.

Diverse Large HIV-1 Non-subtype B Clusters Are Spreading Among Men Who Have Sex With Men in Spain

Dra. Isabel Viciana. Unidad de Microbiología. Hospital Universitario Virgen de la Victoria, Málaga.

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial

Dr. Juan Luis Gómez Sirvent. Sección de infecciones. Hospital Universitario Virgen de las Nieves, Granada.

Switching from a protease inhibitor-based regimen to a dolutegravir-based regimen: a randomized clinical trial to determine the effect on peripheral blood and ileum biopsies from ART-suppressed HIV-infected individuals

Dra. Carmen Hidalgo. FEA de la UGC de Enfermedades Infecciosas. Hospital Universitario Virgen de las Nieves, Granada.

Immediate versus deferred switchin from a boosted protease inhibitor-based regimen to a Dolutegravir-based regimen in virologically suppressed patients with high cardiovascular risk or age? 50 years: final 96-week results of the NEAT022 study

Dra. María Saumoy. Unidad de VIH y ETS. Servicio de Enfermedades Infecciosas. Hospital Universitario Bellvitge, Barcelona

Página 1 de 6123456

Accesos directos